1
|
Degrassi I, Pascuzzi MC, D’Auria E, Fiori L, Dilillo D, Lista G, Castoldi FM, Cavigioli F, Bosetti A, Pellegrinelli A, Zuccotti GV, Verduci E. Non-syndromic bile duct paucity and non-IgE cow’s milk allergy: a case report of challenging nutritional management and maltodextrin intolerance. Ital J Pediatr 2022; 48:175. [PMID: 36109763 PMCID: PMC9479288 DOI: 10.1186/s13052-022-01358-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/26/2022] [Accepted: 08/28/2022] [Indexed: 12/04/2022] Open
Abstract
Background Cholestasis in extremely premature infants (EPI) constitutes a nutritional challenge and maltodextrins have been reported as a possible strategy for hypoglycaemia. We aim to describe the nutritional management of an EPI with non-syndromic bile duct paucity (NSBDP) and feeding intolerance. Case presentation A patient, born at 27 weeks of gestational age, presented cholestatic jaundice at 20 days of life with a clinical picture of NSBDP. Patient’s growth was insufficient with formula rich in medium-chain triglyceride (MCT) and branched-chain amino acids (BCAA). Due to frequent fasting hypoglicemic episodes, maltodextrins supplements were provided. He subsequently presented severe abdominal distension and painful crises, which required hospital admission and withdrawal of maltodextrins. Hypercaloric extensively hydrolysed formula provided weight gain, glycemic control, and parallel improvement in cholestasis. Conclusions Our case suggests caution with the use of maltodextrins in infants, especially if premature. Commercial preparations for hepatopatic patients contain higher concentrations of MCTs and BCAAs, but personalized strategies must be tailored to each patient.
Collapse
|
2
|
Mohanty S, Das K, Anne Correa MM. Non Syndromic Paucity of Interlobular Bile Ducts in Children - A Clinicopathological Study. Fetal Pediatr Pathol 2020; 39:317-333. [PMID: 31437071 DOI: 10.1080/15513815.2019.1652376] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
Background: Non syndromic paucity of interlobular bile ducts (NS-PILBD) constitutes a miniscule of infantile cholestasis. Method: Clinical details, investigations, surgical findings, management and outcome of cases of NS-PILBD at liver biopsy were analyzed. Specific histopathological features including bile duct to portal tract ratio were studied. Results: Eighteen cases (1993-2013) are detailed. Clinical presentation and investigations were similar to biliary atresia. Hepatic scintigraphy showed no gut excretion in 13/18 and operative cholangiogram was normal in all. Liver biopsy showed a median Scheuer fibrosis stage of 2, the mean bile duct/portal tract ratio was 0.29. The average age at last follow up of twelve cases was 54.9 months . Ten were asymptomatic and anicteric, the liver function tests had normalized over 3-15 months. Conclusion: Histopathology differentiated NS-PILBD from other causes of infantile cholestasis .The idiopathic form generally had a favorable long term outcome with medical management.
Collapse
Affiliation(s)
- Suravi Mohanty
- Department of Pathology, St. John's Medical College, Bangalore, India
| | - Kanishka Das
- Department of Pediatric Surgery, All India Institute of Medical Sciences, Bhubaneswar, India
| | | |
Collapse
|
3
|
Brimo Alsaman MZ, Agha S, Sallah H, Badawi R, Kitaz MN, Assani A, Nawfal H. Bilateral anophthalmia and intrahepatic biliary atresia, two unusual components of Fraser syndrome: a case report. BMC Pregnancy Childbirth 2020; 20:358. [PMID: 32522149 PMCID: PMC7288532 DOI: 10.1186/s12884-020-03048-x] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2020] [Accepted: 06/04/2020] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Fraser syndrome or "cryptophthalmos syndrome" is a rare autosomal recessive disease. It is characterized by a group of congenital malformations such as: crytophthalmos, syndactyly, abnormal genitalia, and malformations of the nose, ears, and larynx. Although cryptophthalmos is considered as a main feature of Fraser syndrome, its absence does not exclude the diagnosis. Clinical diagnosis can be made by Thomas Criteria. Here we present the first documented case of Fraser Syndrome in Aleppo, Syria that is characterized by bilateral anophthalmia and intrahepatic biliary atresia. CASE PRESENTATION During pregnancy, several ultrasound scans revealed hyperechoic lungs, ascites, and unremarkable right kidney at the 19th-week visit; bilateral syndactyly on both hands and feet at the 32nd-week visit. On the 39th week of gestation, the stillborn was delivered by cesarean section due to cephalopelvic disproportion. Gross examination showed bilateral anophthalmia, bilateral syndactyly on hands and feet, low set ears, and ambiguous genitalia. Microscopic examination of the lung, spleen, liver, ovary, and kidneys revealed abnormalities in these organs. CONCLUSION The diagnosis of Fraser syndrome can be made prenatally and postnatally; prenatally by ultrasound at 18 weeks of gestation and postnatally by clinical examination using Thomas criteria. Moreover, intrahepatic biliary atresia was not described previously with Fraser syndrome; this recommends a more detailed pathologic study for Fraser syndrome cases.
Collapse
Affiliation(s)
| | - Sarab Agha
- Department of Pathology, Faculty of Medicine, University of Aleppo, Aleppo, Syria
| | - Hala Sallah
- Faculty of Medicine, University of Aleppo, Aleppo, Syria
| | - Rayan Badawi
- Faculty of Medicine, University of Aleppo, Aleppo, Syria
| | | | | | - Hamdi Nawfal
- Department of Embryology, Faculty of Medicine, University of Aleppo, Aleppo, Syria
| |
Collapse
|
4
|
Meena BL, Khanna R, Bihari C, Rastogi A, Rawat D, Alam S. Bile duct paucity in childhood-spectrum, profile, and outcome. Eur J Pediatr 2018; 177:1261-1269. [PMID: 29868931 DOI: 10.1007/s00431-018-3181-3] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/14/2018] [Revised: 05/16/2018] [Accepted: 05/23/2018] [Indexed: 02/07/2023]
Abstract
UNLABELLED We studied the etiological spectrum, clinicolaboratory and histological profile, and outcome of infants and children under 18 years of age presenting between December 2010 and May 2016 with histological evidence of paucity of intralobular bile ducts (PILBD, bile ducts to portal tract ratio < 0.6) Post-transplant PILBD was excluded. Of 632 pediatric liver biopsies screened, 70 had PILBD-44 were infants. PILBD was classified histologically into destructive (n = 50) and non-destructive PILBD (n = 20). Presentations were jaundice (98%), organomegaly (94%), pale stools (50%), and pruritus (43%). Infants had more cholestasis but less fibrosis on histology. Overall, 29 required liver transplantation (LT) for portal hypertension (n = 26), decompensation (n = 25), growth failure (n = 20), intractable pruritus (n = 5), and recurrent cholangitis (n = 2). Destructive PILBD has an odds for poor outcome (decompensation or need for LT within 1 year) of 1.53 (95% CI = 1.15-2.04). On binary logistic regression analysis, poor outcome was related to advanced fibrosis on liver biopsy [Exp (B) = 5.46, 95% CI = 1.56-19.04]. CONCLUSION PILBD was present in 11% of pediatric liver biopsies and has a varied etiological spectrum. Destructive PILBD has poor outcome. Need for LT is guided by the presence of advanced fibrosis. What is Known: • Natural history of syndromic ductal paucity (Alagille syndrome) is complex. • Duct loss is commonly seen with late presentation of biliary atresia. What is New: • The study classifies the etiological spectrum of ductal paucity histologically into destructive and non-destructive. • Destructive duct loss carries poor prognosis regardless of the etiology of liver disease with subsequent need for liver transplantation.
Collapse
Affiliation(s)
- Babu Lal Meena
- Department of Paediatric Hepatology, Institute of Liver and Biliary Sciences, D-1, Vasant Kunj, New Delhi, 110070, India
| | - Rajeev Khanna
- Department of Paediatric Hepatology, Institute of Liver and Biliary Sciences, D-1, Vasant Kunj, New Delhi, 110070, India.
| | - Chhagan Bihari
- Department of Pathology, Institute of Liver and Biliary Sciences, D-1, Vasant Kunj, New Delhi, 110070, India
| | - Archana Rastogi
- Department of Pathology, Institute of Liver and Biliary Sciences, D-1, Vasant Kunj, New Delhi, 110070, India
| | - Dinesh Rawat
- Department of Paediatric Hepatology, Institute of Liver and Biliary Sciences, D-1, Vasant Kunj, New Delhi, 110070, India
| | - Seema Alam
- Department of Paediatric Hepatology, Institute of Liver and Biliary Sciences, D-1, Vasant Kunj, New Delhi, 110070, India
| |
Collapse
|
5
|
Saka R, Yanagihara I, Sasaki T, Nose S, Takeuchi M, Nakayama M, Okuyama H. Immunolocalization of surfactant protein D in the liver from infants with cholestatic liver disease. J Pediatr Surg 2015; 50:297-300. [PMID: 25638623 DOI: 10.1016/j.jpedsurg.2014.11.020] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/25/2014] [Accepted: 11/02/2014] [Indexed: 01/28/2023]
Abstract
PURPOSE Surfactant protein D (SP-D) is one of specific surfactant proteins constituting pulmonary surfactant. Recent studies have revealed that SP-D is detected in various non-pulmonary tissues and is involved in the host defense and immunomodulation. However, the relationship between SP-D and liver diseases has not yet been investigated. The aim of this study was to detect the immunolocalization of SP-D in the livers of infants with cholestatic liver disease. METHODS The expression of immunoreactive SP-D was assessed in infants with cholestasis, including biliary atresia (BA, n=7), neonatal hepatitis (NH, n=2), and paucity of the intrahepatic bile duct (PIBD, n=4). Immunoreactive SP-D was also assessed in six infants who died of non-liver disease as controls. Tissue samples were obtained at liver biopsy, or by post-mortem sampling. The tissue sections were incubated with anti-SP-D polyclonal antibodies and were counterstained with hematoxylin. RESULTS In the normal livers, SP-D was detected in the intrahepatic bile ducts, but was not detected in hepatocytes. In contrast, intense SP-D staining was noted in the hepatocytes from infants with BA, NH, and PIBD. Although SP-D was detected in the intrahepatic bile ducts in the infants with NH, negative or weak staining was seen in the intrahepatic bile ducts in infants with BA. CONCLUSION Our data showed that SP-D is present in the bile ducts of the normal infant liver, and it was found to accumulate in the hepatocytes of cholestatic livers. These results suggest that SP-D is produced in hepatocytes and is secreted into the bile ducts.
Collapse
Affiliation(s)
- Ryuta Saka
- Department of Pediatric Surgery, Hyogo College of Medicine; Department of Pediatric Surgery, Osaka University Graduate School of Medicine.
| | - Itaru Yanagihara
- Department of Developmental Medicine, Osaka Medical Center and Research Institute for Maternal and Child Health
| | - Takashi Sasaki
- Department of Pediatric Surgery, Hyogo College of Medicine
| | - Satoko Nose
- Department of Pediatric Surgery, Hyogo College of Medicine
| | - Makoto Takeuchi
- Department of Pathology and Laboratory Medicine, Osaka Medical Center and Research Institute for Maternal and Child Health
| | - Masahiro Nakayama
- Department of Pathology and Laboratory Medicine, Osaka Medical Center and Research Institute for Maternal and Child Health
| | - Hiroomi Okuyama
- Department of Pediatric Surgery, Hyogo College of Medicine; Department of Pediatric Surgery, Osaka University Graduate School of Medicine
| |
Collapse
|
6
|
Abstract
Perhaps no condition associated with chronic cholestasis is less understood than vanishing bile duct syndrome, a term that refers loosely to the group of acquired disorders associated with progressive destruction and disappearance of the intrahepatic bile ducts and, ultimately, cholestasis. Although the array of insults resulting in poor bile flow is vast, most adult patients who have chronic cholestasis have either primary biliary cirrhosis (or primary sclerosing cholangitis; in some cases, however, a cause cannot be identified. This article reviews the multiple causes, postulated pathophysiology, clinical features, and treatment options for this syndrome.
Collapse
Affiliation(s)
- Nancy S Reau
- Center for Liver Diseases, Section of Gastroenterology, Department of Medicine, University of Chicago Medical Center, 5841 S. Maryland, MC7120, Chicago, IL 60637, USA.
| | | |
Collapse
|
7
|
Rodrigues AF, Gray RG, Preece MA, Brown R, Hill FG, Baumann U, McKiernan PJ. The usefulness of bone marrow aspiration in the diagnosis of Niemann-Pick disease type C in infantile liver disease. Arch Dis Child 2006; 91:841-4. [PMID: 16737996 PMCID: PMC2066037 DOI: 10.1136/adc.2005.088013] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
BACKGROUND Niemann-Pick disease type C (NPC) is a fatal, autosomal recessive lysosomal storage disease which may present in infancy with cholestatic jaundice and/or hepatosplenomegaly. In cholestatic patients with splenomegaly, a bone marrow aspirate has been advocated as a relatively accessible tissue to demonstrate storage phenomena. Typically in patients with NPC, macrophages with abnormal cholesterol storage, so called foam cells, can be detected in the bone marrow. AIM To review our experience of bone marrow aspiration in children with NPC presenting with infantile liver disease. METHODS A retrospective analysis of 11 consecutive children (8 males) from Birmingham Children's Hospital with NPC presenting with infantile liver disease was undertaken. The diagnosis of NPC was confirmed in all cases by demonstrating undetectable or low rates of cholesterol esterification and positive filipin staining for free cholesterol in cultured fibroblasts. RESULTS The median age at presentation was 1.5 months (range 0.5-10). Bone marrow aspirates showed storage cells in only 7/11 cases. Bone marrow aspirates which had storage cells were undertaken at a median age of 11 months while those with no storage cells were undertaken at median age 2.3 months. The overall sensitivity of bone marrow aspirates for detecting storage cells in children presenting with infantile liver disease was 64%; however, for children who had bone marrow aspirates in the first year of life it was only 57%. CONCLUSIONS The sensitivity of bone marrow aspirate for the diagnosis of NPC disease in patients presenting with infantile liver disease was lower than previously reported. Where NPC is suspected clinically, definitive investigations should be undertaken promptly. There is a need to develop sensitive screening methods for NPC in children presenting with infantile liver disease.
Collapse
Affiliation(s)
- A F Rodrigues
- Liver Unit, Birmingham Children's Hospital, Birmingham, UK.
| | | | | | | | | | | | | |
Collapse
|
8
|
De Tommaso AMA, Kawasaki AS, Hessel G. Paucity of intrahepatic bile ducts in infancy: experience of a tertiary center. ARQUIVOS DE GASTROENTEROLOGIA 2004; 41:190-2. [PMID: 15678205 DOI: 10.1590/s0004-28032004000300010] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
BACKGROUND: Intrahepatic cholestasis secondary to paucity of bile duct is an alteration of the anatomic integrity of the biliary tract. Can be defined only histologically and, clinically, two categories are recognized: syndromic and non-syndromic, where the prognosis is generally more severe. AIM: To evaluate the history, clinical and biochemical characteristics, etiology and improvement of children who have paucity of intrahepatic bile duct followed at tertiary center. PATIENTS AND METHODS: Eleven children with paucity of intrahepatic bile duct, followed at the Pediatric Hepatology Service of the University Hospital, Campinas, SP, Brazil, were evaluated in the period from 1986 to 2001. RESULTS: Among the patients, three presented the syndromic and eight the non-syndromic form (two with alpha-1-antitrypsin deficiency, one with lues, one secondary to sepsis, three with probable etiology by cytomegalovirus and one without a definite etiology). Referral ranged from 31 to 1185 days. Birth weights ranged from 1920 g to 3590 g. Most of the patients presented pale stools. The median bile duct/portal tract ratio was 0.14. The majority of the children presented a favorable follow-up, regardless of the form of presentation. CONCLUSION: Paucity of intrahepatic bile ducts should be considered in children with cholestasis and its differentiation from extrahepatic causes of neonatal cholestasis is important in order to avoid surgery. Diagnosis of non-syndromic form should not be regarded as unfavorable prognosis, as the evolution is probably related to the etiology in this form of presentation.
Collapse
|
9
|
Yehezkely-Schildkraut V, Munichor M, Mandel H, Berkowitz D, Hartman C, Eshach-Adiv O, Shamir R. Nonsyndromic paucity of interlobular bile ducts: report of 10 patients. J Pediatr Gastroenterol Nutr 2003; 37:546-9. [PMID: 14581794 DOI: 10.1097/00005176-200311000-00007] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Abstract
OBJECTIVES Only a few reports of nonsyndromic paucity of interlobular bile ducts (NS-PILBD) have been published. The authors' aim was to outline the clinical and laboratory profile of patients with NS-PILBD diagnosed at a tertiary referral center. METHODS The authors reviewed all the reports of pediatric liver biopsies performed between 1991 and 2000 at their institution. Upon diagnosis of NS-PILBD, patients' records were examined for clinical, laboratory, and histologic data, and liver biopsy specimens were re-evaluated. RESULTS Three hundred biopsies were performed in children during the study period, of which 64 were in infants younger than 1 year. NS-PILBD was diagnosed in 10 of 64 (16%) biopsy specimens. Mean age at presentation was 10 days (range, 1 day-6 weeks), and mean follow-up was 4.5 years (range, 1-9 years). An underlying condition was identified in 70% of children with NS-PILBD: namely congenital cytomegalovirus (n = 2), progressive familial intrahepatic cholestasis (PFIC, n = 2), mitochondrial DNA depletion (n = 1), Niemann-Pick type C (n = 1), and arthrogryposis multiplex congenita, renal dysfunction, and cholestasis (ARC syndrome; n = 1). All children presented with jaundice. Four children had initially acholic stools. At their last follow-up visit, failure to thrive was present in five children, and cholestasis in six children. Mortality was noted only in children with metabolic diseases (n = 2). CONCLUSIONS In the study, NS-PILBD was common in young children undergoing liver biopsy. Although NS-PILBD is nonspecific, a wide survey for inborn errors of metabolism should be included in the diagnostic work-up of NS-PILBD. In the authors' center, the association of certain metabolic diseases with NS-PILBD carries a grave prognosis.
Collapse
|
10
|
Affiliation(s)
- William F Balistreri
- Children's Hospital Medical Center and University of Cincinnati, Cincinnati, Ohio, USA
| |
Collapse
|
11
|
Abstract
The early detection of cholestatic liver disease is one of the major challenges facing pediatricians when evaluating the jaundiced infant. Early recognition of liver disease greatly facilitates the care and outcome of infants, because several serious life-threatening disorders may have cholestasis as a major presenting sign of underlying neonatal liver disease. A key component of the work-up is measurement of serum conjugated bilirubin levels, which if elevated should prompt the clinician to initiate a work-up to determine the cause of neonatal cholestasis. In general, if a patient is developing progressive jaundice soon after birth, is still jaundiced at 2 weeks of life, or develops jaundice within the first month of life, a work-up for neonatal cholestasis should begin. A number of previously undiagnosed causes of neonatal cholestasis are beginning to be assigned genetic and infectious etiologies, with significant implications for the work-up and management of cholestatic infants.
Collapse
Affiliation(s)
- Saul J Karpen
- Department of Pediatrics, Texas Children's Liver Center, Baylor College of Medicine, Houston, Texas, USA.
| |
Collapse
|
12
|
Drouin E, Russo P, Tuchweber B, Mitchell G, Rasquin-Weber A. North American Indian cirrhosis in children: a review of 30 cases. J Pediatr Gastroenterol Nutr 2000; 31:395-404. [PMID: 11045837 DOI: 10.1097/00005176-200010000-00013] [Citation(s) in RCA: 50] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
BACKGROUND North American Indian childhood cirrhosis (NAIC) is a distinct, rapidly evolving form of familial cholestasis found in aboriginal children from northwestern Quebec. This is a retrospective review of the 30 patients treated in Quebec since the discovery of NAIC in 1970. METHODS The clinical records and histologic samples from 30 patients were reviewed. Extensive metabolic, biochemical, viral, genetic, and radiologic studies were performed in most patients. RESULTS Genetic analysis suggests autosomal recessive inheritance and a carrier frequency of 10% in this population. Gene mapping studies showed that the NAIC gene is located on chromosome 16q22. Typically, patients have neonatal cholestatic jaundice (70%) or hepatosplenomegaly (20%) with resolution of clinical jaundice by age 1 year but persistent direct hyperbilirubinemia. Portal hypertension was documented in 29 patients (91%). Variceal bleeding (15 patients, 50%) occurred as early as age 10 months. Surgical portosystemic shunting was performed in 13 of these 15 patients (87%); 4 (31%) rebled after 1 to 5 years. Fourteen patients died (47%). In 10 (71%), liver disease was the cause. Four children died of liver failure before liver transplantation became available. In transplanted livers, no recurrence of NAIC was observed after 1 to 10 years. Recognized infectious, metabolic, toxic, autoimmune, and obstructive causes of cirrhosis have been eliminated. The histologic features of NAIC show early bile duct proliferation and rapid development of portal fibrosis and biliary cirrhosis, suggesting a cholangiopathic phenomenon. CONCLUSION Together with gene mapping studies showing that the NAIC gene is different from those of other familial cholestases, these observations suggest that NAIC is a distinct entity that could be classified as "progressive familial cholangiopathy."
Collapse
Affiliation(s)
- E Drouin
- Department of Pediatrics, Hôpital Ste-Justine, Montréal, Quebec, Canada
| | | | | | | | | |
Collapse
|
13
|
Bétard C, Rasquin-Weber A, Brewer C, Drouin E, Clark S, Verner A, Darmond-Zwaig C, Fortin J, Mercier J, Chagnon P, Fujiwara TM, Morgan K, Richter A, Hudson TJ, Mitchell GA. Localization of a recessive gene for North American Indian childhood cirrhosis to chromosome region 16q22-and identification of a shared haplotype. Am J Hum Genet 2000; 67:222-8. [PMID: 10820129 PMCID: PMC1287080 DOI: 10.1086/302993] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/1999] [Accepted: 04/12/2000] [Indexed: 12/14/2022] Open
Abstract
North American Indian childhood cirrhosis (NAIC, or CIRH1A) is an isolated nonsyndromic form of familial cholestasis reported in Ojibway-Cree children and young adults in northwestern Quebec. The pattern of transmission is consistent with an autosomal recessive mode of inheritance. To map the NAIC locus, we performed a genomewide scan on three DNA pools of samples from 13 patients, 16 unaffected siblings, and 22 parents from five families. Analysis of 333 highly polymorphic markers revealed 3 markers with apparent excess allele sharing among affected individuals. Additional mapping identified a chromosome 16q segment shared by all affected individuals. When the program FASTLINK/LINKAGE was used and a completely penetrant autosomal recessive mode of inheritance was assumed, a maximum LOD score of 4.44 was observed for a recombination fraction of 0, with marker D16S3067. A five-marker haplotype (D16S3067, D16S752, D16S2624, D16S3025, and D16S3106) spanning 4.9 cM was shared by all patients. These results provide significant evidence of linkage for a candidate gene on chromosome 16q22.
Collapse
Affiliation(s)
- Christine Bétard
- Montreal Genome Centre, Montreal General Hospital Research Institute; Services de Gastroenterologie and Génétique Médicale, Département de Pédiatrie, Hôpital Sainte-Justine, Université de Montréal; and Departments of Human Genetics and Medicine, McGill University, Montréal
| | - Andrée Rasquin-Weber
- Montreal Genome Centre, Montreal General Hospital Research Institute; Services de Gastroenterologie and Génétique Médicale, Département de Pédiatrie, Hôpital Sainte-Justine, Université de Montréal; and Departments of Human Genetics and Medicine, McGill University, Montréal
| | - Carl Brewer
- Montreal Genome Centre, Montreal General Hospital Research Institute; Services de Gastroenterologie and Génétique Médicale, Département de Pédiatrie, Hôpital Sainte-Justine, Université de Montréal; and Departments of Human Genetics and Medicine, McGill University, Montréal
| | - Eric Drouin
- Montreal Genome Centre, Montreal General Hospital Research Institute; Services de Gastroenterologie and Génétique Médicale, Département de Pédiatrie, Hôpital Sainte-Justine, Université de Montréal; and Departments of Human Genetics and Medicine, McGill University, Montréal
| | - Suzanne Clark
- Montreal Genome Centre, Montreal General Hospital Research Institute; Services de Gastroenterologie and Génétique Médicale, Département de Pédiatrie, Hôpital Sainte-Justine, Université de Montréal; and Departments of Human Genetics and Medicine, McGill University, Montréal
| | - Andrei Verner
- Montreal Genome Centre, Montreal General Hospital Research Institute; Services de Gastroenterologie and Génétique Médicale, Département de Pédiatrie, Hôpital Sainte-Justine, Université de Montréal; and Departments of Human Genetics and Medicine, McGill University, Montréal
| | - Corinne Darmond-Zwaig
- Montreal Genome Centre, Montreal General Hospital Research Institute; Services de Gastroenterologie and Génétique Médicale, Département de Pédiatrie, Hôpital Sainte-Justine, Université de Montréal; and Departments of Human Genetics and Medicine, McGill University, Montréal
| | - Julie Fortin
- Montreal Genome Centre, Montreal General Hospital Research Institute; Services de Gastroenterologie and Génétique Médicale, Département de Pédiatrie, Hôpital Sainte-Justine, Université de Montréal; and Departments of Human Genetics and Medicine, McGill University, Montréal
| | - Jocelyne Mercier
- Montreal Genome Centre, Montreal General Hospital Research Institute; Services de Gastroenterologie and Génétique Médicale, Département de Pédiatrie, Hôpital Sainte-Justine, Université de Montréal; and Departments of Human Genetics and Medicine, McGill University, Montréal
| | - Pierre Chagnon
- Montreal Genome Centre, Montreal General Hospital Research Institute; Services de Gastroenterologie and Génétique Médicale, Département de Pédiatrie, Hôpital Sainte-Justine, Université de Montréal; and Departments of Human Genetics and Medicine, McGill University, Montréal
| | - T. Mary Fujiwara
- Montreal Genome Centre, Montreal General Hospital Research Institute; Services de Gastroenterologie and Génétique Médicale, Département de Pédiatrie, Hôpital Sainte-Justine, Université de Montréal; and Departments of Human Genetics and Medicine, McGill University, Montréal
| | - Kenneth Morgan
- Montreal Genome Centre, Montreal General Hospital Research Institute; Services de Gastroenterologie and Génétique Médicale, Département de Pédiatrie, Hôpital Sainte-Justine, Université de Montréal; and Departments of Human Genetics and Medicine, McGill University, Montréal
| | - Andrea Richter
- Montreal Genome Centre, Montreal General Hospital Research Institute; Services de Gastroenterologie and Génétique Médicale, Département de Pédiatrie, Hôpital Sainte-Justine, Université de Montréal; and Departments of Human Genetics and Medicine, McGill University, Montréal
| | - Thomas J. Hudson
- Montreal Genome Centre, Montreal General Hospital Research Institute; Services de Gastroenterologie and Génétique Médicale, Département de Pédiatrie, Hôpital Sainte-Justine, Université de Montréal; and Departments of Human Genetics and Medicine, McGill University, Montréal
| | - Grant A. Mitchell
- Montreal Genome Centre, Montreal General Hospital Research Institute; Services de Gastroenterologie and Génétique Médicale, Département de Pédiatrie, Hôpital Sainte-Justine, Université de Montréal; and Departments of Human Genetics and Medicine, McGill University, Montréal
| |
Collapse
|